Amphastar Pharmaceuticals (AMPH) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChartTranscripts

Amphastar Pharmaceuticals Revenue Highlights


Latest Revenue (Y)

$593.24M

Latest Revenue (Q)

$188.82M

Main Segment (Y)

Active Pharmaceutical Ingredient Segment

Main Geography (Y)

U

Amphastar Pharmaceuticals Revenue by Period


Amphastar Pharmaceuticals Revenue by Year

DateRevenueChange
2023-12-31$593.24M18.89%
2022-12-31$498.99M13.98%
2021-12-31$437.77M25.13%
2020-12-31$349.85M8.53%
2019-12-31$322.36M9.40%
2018-12-31$294.67M22.69%
2017-12-31$240.18M-5.87%
2016-12-31$255.16M1.45%
2015-12-31$251.52M19.51%
2014-12-31$210.46M-8.37%
2013-12-31$229.68M12.41%
2012-12-31$204.32M72.63%
2011-12-31$118.36M-

Amphastar Pharmaceuticals generated $593.24M in revenue during NA 2023, up 18.89% compared to the previous quarter, and up 201.33% compared to the same period a year ago.

Amphastar Pharmaceuticals Revenue by Quarter

DateRevenueChange
2024-09-30$188.82M3.52%
2024-06-30$182.39M6.14%
2024-03-31$171.84M-3.52%
2023-12-31$178.10M-1.36%
2023-09-30$180.56M23.91%
2023-06-30$145.71M4.06%
2023-03-31$140.02M3.70%
2022-12-31$135.02M12.40%
2022-09-30$120.13M-2.70%
2022-06-30$123.47M2.57%
2022-03-31$120.37M-0.43%
2021-12-31$120.89M7.74%
2021-09-30$112.20M10.36%
2021-06-30$101.66M-1.32%
2021-03-31$103.02M7.40%
2020-12-31$95.92M14.97%
2020-09-30$83.43M-2.77%
2020-06-30$85.81M1.32%
2020-03-31$84.69M1.57%
2019-12-31$83.38M4.05%
2019-09-30$80.14M1.38%
2019-06-30$79.05M-0.93%
2019-03-31$79.79M-11.04%
2018-12-31$89.69M18.73%
2018-09-30$75.54M6.34%
2018-06-30$71.04M21.66%
2018-03-31$58.39M-3.33%
2017-12-31$60.40M4.29%
2017-09-30$57.92M-11.15%
2017-06-30$65.19M15.03%
2017-03-31$56.67M-10.82%
2016-12-31$63.54M-1.06%
2016-09-30$64.22M-5.60%
2016-06-30$68.03M14.60%
2016-03-31$59.37M-22.81%
2015-12-31$76.91M20.42%
2015-09-30$63.87M18.60%
2015-06-30$53.85M-5.33%
2015-03-31$56.89M1.81%
2014-12-31$55.88M-6.42%
2014-09-30$59.71M21.85%
2014-06-30$49.00M6.83%
2014-03-31$45.87M-16.41%
2013-12-31$54.88M-7.49%
2013-09-30$59.32M-5.13%
2013-06-30$62.52M18.05%
2013-03-31$52.96M-

Amphastar Pharmaceuticals generated $188.82M in revenue during Q3 2024, up 3.52% compared to the previous quarter, and up 129.58% compared to the same period a year ago.

Amphastar Pharmaceuticals Revenue Breakdown


Amphastar Pharmaceuticals Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 20Dec 19Dec 18
Active Pharmaceutical Ingredient Segment$18.48M$20.36M$23.61M

Amphastar Pharmaceuticals's latest annual revenue breakdown by segment (product or service), as of Dec 20: Active Pharmaceutical Ingredient Segment (100.00%).

Quarterly Revenue by Product

Product/ServiceSep 24Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Dec 18Sep 18Jun 18Mar 18
Product and Service, Other$2.40M--------------
Product$188.82M--------------
Active Pharmaceutical Ingredient Segment-$6.94M$5.14M$8.12M$2.10M$4.87M$3.39M$5.39M$4.41M$5.31M$5.25M$3.78M$7.80M$5.28M-
Finished Pharmaceutical Products Segment-----------$82.93M---

Amphastar Pharmaceuticals's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (98.75%), and Product and Service, Other (1.25%).

Amphastar Pharmaceuticals Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 20Dec 19Dec 18
Active Pharmaceutical Ingredient Segment$18.48M--
C$3.16M$1.48M-
U$333.09M$304.90M$279.12M

Amphastar Pharmaceuticals's latest annual revenue breakdown by geography, as of Dec 20: U (93.90%), Active Pharmaceutical Ingredient Segment (5.21%), and C (0.89%).

Quarterly Revenue by Country

CountrySep 24Jun 21Mar 21Dec 20Sep 20Jun 20Mar 20Dec 19Sep 19Jun 19Mar 19Sep 18Jun 18Mar 18
CHINA$178.00K-------------
FRANCE$4.52M-------------
UNITED STATES$186.51M-------------
C-$1.13M$1.12M$679.00K$1.96M$295.00K$228.00K$438.00K$59.00K$984.00K----
U-$95.19M$99.17M$90.72M$79.41M$81.90M$81.06M$77.59M$76.07M$74.78M$76.46M$72.48M$68.56M$53.10M
Active Pharmaceutical Ingredient Segment-$6.94M------------

Amphastar Pharmaceuticals's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (97.54%), FRANCE (2.36%), and CHINA (0.09%).

Amphastar Pharmaceuticals Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
NBIXNeurocrine Biosciences$1.89B$622.10M
ALKSAlkermes$1.66B$378.14M
PBHPrestige Consumer Healthcare$1.13B$283.55M
PAHCPhibro Animal Health$977.89M$273.16M
EVOEvotec SE$781.43M$208.73M
PCRXPacira BioSciences$674.98M$168.57M
SUPNSupernus Pharmaceuticals$607.52M$175.69M
AMPHAmphastar Pharmaceuticals$593.24M$188.82M
COLLCollegium Pharmaceutical$566.77M$159.30M
ANIPANI Pharmaceuticals$486.82M$148.33M
IRWDIronwood Pharmaceuticals$442.74M$91.59M
EGRXEagle Pharmaceuticals$316.61M$64.65M
EOLSEvolus$199.72M$60.16M
DCPHDeciphera Pharmaceuticals$163.36M$45.00M

AMPH Revenue FAQ


What is Amphastar Pharmaceuticals’s yearly revenue?

Amphastar Pharmaceuticals's yearly revenue for 2023 was $593.24M, representing an increase of 18.89% compared to 2022. The company's yearly revenue for 2022 was $498.99M, representing an increase of 13.98% compared to 2021. AMPH's yearly revenue for 2021 was $437.77M, representing an increase of 25.13% compared to 2020.

What is Amphastar Pharmaceuticals’s quarterly revenue?

Amphastar Pharmaceuticals's quarterly revenue for Q3 2024 was $188.82M, a 3.52% increase from the previous quarter (Q2 2024), and a 4.58% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $182.39M, a 6.14% increase from the previous quarter (Q1 2024), and a 25.17% increase year-over-year (Q2 2023). AMPH's quarterly revenue for Q1 2024 was $171.84M, a -3.52% decrease from the previous quarter (Q4 2023), and a 22.72% increase year-over-year (Q1 2023).

What is Amphastar Pharmaceuticals’s revenue growth rate?

Amphastar Pharmaceuticals's revenue growth rate for the last 3 years (2021-2023) was 35.51%, and for the last 5 years (2019-2023) was 84.03%.

What are Amphastar Pharmaceuticals’s revenue streams?

Amphastar Pharmaceuticals's revenue streams in c 20 are Active Pharmaceutical Ingredient Segment

What is Amphastar Pharmaceuticals’s main source of revenue?

For the fiscal year ending Dec 20, the largest source of revenue of Amphastar Pharmaceuticals was Active Pharmaceutical Ingredient Segment. This segment made a revenue of $18.48M, representing 100.00% of the company's total revenue.